Trials / Completed
CompletedNCT02707224
Clinical Trial to Compare the Pharmacokinetics of DP-R208
A Randomized, Single-dose, Open, Crossover Clinical Trial to Compare the Pharmacokinetics of DP-R208 (Candesartan Cilexetil and Rosuvastatin Calcium Fixed Dose Combinations) in Comparison to Each Component Administered Alone in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Alvogen Korea · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A randomized, single-dose, open, crossover clinical trial to compare the pharmacokinetics of DP-R208 (Candesartan cilexetil and Rosuvastatin calcium fixed dose combinations) in comparison to each component administered alone in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DP-R208 | Investigational product is prescribed to all of randomized subjects |
| DRUG | Candesartan cilexetil | Investigational product is prescribed to all of randomized subjects |
| DRUG | Rosuvastatin | Investigational product is prescribed to all of randomized subjects |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2016-03-14
- Last updated
- 2016-03-23
Source: ClinicalTrials.gov record NCT02707224. Inclusion in this directory is not an endorsement.